Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine

J. Bellmunt; J. Albanell; L. Paz-Ares; M.A. Climent; J.L. González-Larriba; J.J. de la Cruz; V. Guillem; E. Díaz-Rubio; H. Cortés-Funes; J.(HVH) Baselga; Joan Carles Galceran

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine

J. Bellmunt, J. Albanell, L. Paz-Ares, M.A. Climent, J.L. González-Larriba, J.J. de la Cruz, V. Guillem, E. Díaz-Rubio, H. Cortés-Funes, J.(HVH) Baselga, Joan Carles Galceran

Department of Medicine

Research output: Contribution to journal › Article › Research

122 Citations (Scopus)

Original language	English
Pages (from-to)	751-757
Journal	Cancer
Volume	95
Issue number	4
Publication status	Published - 1 Aug 2002

Cite this

Bellmunt, J., Albanell, J., Paz-Ares, L., Climent, M. A., González-Larriba, J. L., de la Cruz, J. J., Guillem, V., Díaz-Rubio, E., Cortés-Funes, H., Baselga, J., & Carles Galceran, J. (2002). Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine. Cancer, 95(4), 751-757.

Bellmunt, J. ; Albanell, J. ; Paz-Ares, L. ; Climent, M.A. ; González-Larriba, J.L. ; de la Cruz, J.J. ; Guillem, V. ; Díaz-Rubio, E. ; Cortés-Funes, H. ; Baselga, J.(HVH) ; Carles Galceran, Joan. / Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine. In: Cancer. 2002 ; Vol. 95, No. 4. pp. 751-757.

@article{e70729d8780349e8a5bc8924cb52e6ca,

title = "Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine",

author = "J. Bellmunt and J. Albanell and L. Paz-Ares and M.A. Climent and J.L. Gonz{\'a}lez-Larriba and {de la Cruz}, J.J. and V. Guillem and E. D{\'i}az-Rubio and H. Cort{\'e}s-Funes and J.(HVH) Baselga and {Carles Galceran}, Joan",

year = "2002",

month = aug,

day = "1",

language = "English",

volume = "95",

pages = "751--757",

number = "4",

}

Bellmunt, J, Albanell, J, Paz-Ares, L, Climent, MA, González-Larriba, JL, de la Cruz, JJ, Guillem, V, Díaz-Rubio, E, Cortés-Funes, H, Baselga, J & Carles Galceran, J 2002, 'Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine', Cancer, vol. 95, no. 4, pp. 751-757.

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine. / Bellmunt, J.; Albanell, J.; Paz-Ares, L.; Climent, M.A.; González-Larriba, J.L.; de la Cruz, J.J.; Guillem, V.; Díaz-Rubio, E.; Cortés-Funes, H.; Baselga, J.(HVH); Carles Galceran, Joan.

In: Cancer, Vol. 95, No. 4, 01.08.2002, p. 751-757.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II with paclitaxel, cisplatin, and gemcitabine

AU - Bellmunt, J.

AU - Albanell, J.

AU - Paz-Ares, L.

AU - Climent, M.A.

AU - González-Larriba, J.L.

AU - de la Cruz, J.J.

AU - Guillem, V.

AU - Díaz-Rubio, E.

AU - Cortés-Funes, H.

AU - Baselga, J.(HVH)

AU - Carles Galceran, Joan

PY - 2002/8/1

Y1 - 2002/8/1

M3 - Article

VL - 95

SP - 751

EP - 757

IS - 4

ER -